Treatment of exudative age‐related macular degeneration with aflibercept combined with pranoprofen eye drops or nutraceutical support with omega‐3: A randomized trial

@article{Semeraro2019TreatmentOE,
  title={Treatment of exudative age‐related macular degeneration with aflibercept combined with pranoprofen eye drops or nutraceutical support with omega‐3: A randomized trial},
  author={F. Semeraro and Elena Gambicordi and A. Cancarini and F. Morescalchi and C. Costagliola and A. Russo},
  journal={British Journal of Clinical Pharmacology},
  year={2019},
  volume={85},
  pages={908 - 913}
}
  • F. Semeraro, Elena Gambicordi, +3 authors A. Russo
  • Published 2019
  • Medicine
  • British Journal of Clinical Pharmacology
  • The aim of this study was to determine whether a combination of intravitreal aflibercept (IVA) and pranoprofen eyedrops or nutraceutical support provides additional benefit over IVA monotherapy for the treatment of choroidal neovascularization (CNV) in age‐related macular degeneration. 
    2 Citations

    References

    SHOWING 1-10 OF 36 REFERENCES
    Ranibizumab in neovascular age-related macular degeneration
    • 1,735
    • Highly Influential
    Topical Nonsteroidal Anti-Inflammatory Drugs for Macular Edema
    • 38
    • PDF